S27 Molecular Classifications of Adrenal Tumors in the Genomics Era

Program: Symposia
Basic Session
Saturday, April 2, 2016: 8:15 AM-9:45 AM
Room 160 (BCEC)
Margaret E Wierman, MD, University of Colorado School of Medicine and Research Service VAMC, Aurora,

Nothing to Disclose: MEW
8:15 AM
Emilia Modolo Pinto, PhD, Pathology, St. Jude Children's Research Hospital, Memphis, TN
Nothing to Disclose: EMP
8:45 AM
Nelly Burnichon, PharmD, PhD, Team 13, INSERM U970, Paris, France
Nothing to Disclose: NB
9:15 AM
Siyuan Zheng, PhD, Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Nothing to Disclose: SZ
See more of: Symposia


The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire